Fifty subjects (male and female) were randomized to receive 250 mg of ForsLean® or placebo capsules twice a day (morning and evening) half-an-hour before meals for 12 weeks. A significant decrease in body weight and fat content and a significant increase in lean body mass (p<0.05) was observed.
A 3-month, randomized, double-blind study results from 60 overweight volunteers demonstrated that consumption of capsules containing 250 mg of ForsLean® b.i.d produced a significant reduction in body weight and body fat when compared to placebo group. In conclusion, ForsLean® may be said to have a weight and fat reduction property, and could preserve lean body mass as well. No subjective or objective side effects in the active group were observed.
Twenty-four obese female subjects with BMI ranging from 28–45 (I degree to III degree obesity) were evaluated for the effect of ForsLean® on lean body mass and weight loss. Subjects were given 250 mg of ForsLean® capsules twice daily 30 min. before breakfast and dinner for 3 months.
ForsLean® demonstrated a significant increase in lean body mass with a corresponding reduction in body weight, BMI and fat content. Thus, it was concluded that good tolerability of ForsLean® along with its weight loss efficacy makes it an attractive option in the treatment of obesity.